Delivery Order SPE2DB22D2005-SPE2DB24FJHQ7
- Not listed
- This federal contract award, valued at $2,112.67, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order against an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which has a ceiling value of...
- This federal contract award, valued at $3,892.98, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product REXULTI 0.5 MG TABLET 30S. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products and medical supplies. The award, valued at $10,287.85, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers a wide range of medical commodities,...
- This federal contract award, valued at $1,972.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of May 2, 2023 and is a Firm Fixed Price Delivery Order contract. The contract is not designated with any set-aside requirements, indicating it was awarded through full and open competition. Amerisourcebergen...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The $6,989.87 firm fixed-price award is for the delivery of REXULTI 3 MG TABLET 30S, a pharmaceutical product, to support federal healthcare programs. The DLA Troop Support Medical IDC, valued at up to $999,999,999.00, serves as the primary contracting vehicle for Amerisourcebergen to...
- This federal contract award, valued at $26,017.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $13,888.80 firm fixed-price delivery order is for the supply of REXULTI 3 MG TABLET 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This single-award IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,401.81 firm-fixed-price delivery order is for the supply of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The award is not designated under any set-aside program, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $16,305.29 delivery order contract is for the supply of REXULTI 1 MG TABLET 30S, a pharmaceutical product, and has a completion date of January 31, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $13,956.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of 4563218543 - REXULTI 1 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 4, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00,...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB24FJHQ7Delivery Order
This federal contract award, valued at $15,470.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides pharmaceutical products and medical supplies to support military healthcare programs globally. The specific delivery order is for 4563742520 REXULTI 2 MG TABLET 30S, a prescription medication. This award does not have a set-aside designation, indicating full and open competition. As a major pharmaceutical distributor, Amerisourcebergen Drug Corp plays a critical role in supplying essential medical commodities to federal agencies, including the Department of Defense and Department of Veterans Affairs healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 2/12/24 |